{"organizations": [], "uuid": "2e74cd5b4c07916c4277d83c42d16a920b2d4c0b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180223.html", "section_title": "Archive News &amp; Video for Friday, 23 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-navidea-biopharmaceuticals-says-on/brief-navidea-biopharmaceuticals-says-on-feb-17-co-entered-into-settlement-agreement-and-mutual-release-with-sinotau-idUSFWN1QD1C7", "country": "US", "domain_rank": 408, "title": "BRIEF-Navidea Biopharmaceuticals says ‍On Feb 17, co Entered Into Settlement Agreement And Mutual Release With Sinotau", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.402, "site_type": "news", "published": "2018-02-24T00:10:00.000+02:00", "replies_count": 0, "uuid": "2e74cd5b4c07916c4277d83c42d16a920b2d4c0b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-navidea-biopharmaceuticals-says-on/brief-navidea-biopharmaceuticals-says-on-feb-17-co-entered-into-settlement-agreement-and-mutual-release-with-sinotau-idUSFWN1QD1C7", "ord_in_thread": 0, "title": "BRIEF-Navidea Biopharmaceuticals says ‍On Feb 17, co Entered Into Settlement Agreement And Mutual Release With Sinotau", "locations": [], "entities": {"persons": [{"name": "navidea", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "navidea biopharmaceuticals inc", "sentiment": "negative"}, {"name": "brief-navidea biopharmaceuticals", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "navidea biopharmaceuticals - co", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 23 (Reuters) - Navidea Biopharmaceuticals Inc:\n* NAVIDEA BIOPHARMACEUTICALS INC - ‍ON FEBRUARY 17, 2018, NAVIDEA ENTERED INTO A SETTLEMENT AGREEMENT AND MUTUAL RELEASE WITH SINOTAU - SEC FILING​\n* NAVIDEA BIOPHARMACEUTICALS - CO, SINOTAU AGREED TO STIPULATE TO VOLUNTARILY DISMISSAL OF ALL CLAIMS AGAINST EACH OTHER WITH PREJUDICE​ Source text - ( bit.ly/2osYMPY ) Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2osYMPY"], "published": "2018-02-24T00:10:00.000+02:00", "crawled": "2018-02-24T13:38:51.006+02:00", "highlightTitle": ""}